Jump to content

George D. LeMaitre: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Declining submission: corp - Submission is about a company or organization not yet shown to meet notability guidelines (AFCH 0.9.1)
Made a minor text tweak to the last paragraph and updated references throughout to better demonstrate notability.
Line 5: Line 5:
----
----


'''LeMaitre Vascular''' is a provider of devices, implants and human tissue cryopreservation services used by surgeons in the treatment of vascular conditions, particularly [[peripheral vascular disease]].<ref>{{Cite web|url=https://finance.yahoo.com/news/top-picks-2020-lemaitre-vascular-100000653.html|title=Top Picks 2020- LeMaitre Vascular LMAT|website=finance.yahoo.com}}</ref>Headquartered in Burlington, Massachusetts, LeMaitre Vascular sells directly to hospitals in 22 countries and through distributors in more than 60 countries throughout North America, Europe and Asia/Pacific Rim.<ref>{{Cite web|url=https://www.sec.gov/Archives/edgar/data/1158895/000119312517074936/d310314d10k.htm|title=Form 10-K|website=www.sec.gov}}</ref>
'''LeMaitre Vascular''' is a provider of devices, implants and human tissue cryopreservation services used by surgeons in the treatment of vascular conditions, particularly [[Wikipedia:Osmosis/Peripheral_vascular_disease|peripheral vascular disease]].<ref>https://www.moneyshow.com/articles/tptp2020-53340/top-picks-2020-lemaitre-vascular-lmat/</ref> Headquartered in Burlington, Massachusetts, LeMaitre Vascular sells directly to hospitals in 22 countries and through distributors in more than 60 countries throughout North America, Europe and Asia/Pacific Rim.<ref>https://www.sec.gov/Archives/edgar/data/1158895/000119312517074936/d310314d10k.htm</ref>


The company was founded in 1983 by George D. LeMaitre, M.D., a practicing vascular surgeon who wasn’t satisfied with the [[in situ]] devices that were available to him. He worked with an engineer to design a new device himself. His first patented creation was a type of [[valvulotome]] that could be used by a surgeon to cut valves in peripheral veins without the requirement of direct vision.<ref>{{Cite web|url=https://patents.google.com/patent/US5658301A/en|title=Self-centering valvulotome}}</ref> As a result, the surgeon could prepare veins for arterial bypass with smaller incisions and less tissue trauma.<ref>{{Cite journal|url=https://jamanetwork.com/journals/jamasurgery/fullarticle/592908|title=In Situ Grafting Made Easy: Modification of a Technique|first1=George D.|last1=LeMaitre|first2=Michael J.|last2=Arakelian|date=January 1, 1988|journal=Archives of Surgery|volume=123|issue=1|pages=101–103|via=jamanetwork.com|doi=10.1001/archsurg.1988.01400250111022}}</ref> Dr. LeMaitre was so pleased with the success of his new device that he started a company to introduce the LeMaitre Valvulotome to his colleagues. In the ensuing years, Dr. LeMaitre’s son, George W. LeMaitre, joined the company and helped grow it from a family-owned company to a publicly held global corporation.
The company was founded in 1983 by George D. LeMaitre, M.D., a practicing vascular surgeon who wasn’t satisfied with the [[In_situ|in situ]] devices that were available to him. He worked with an engineer to design a new device himself. His first patented creation was a type of [[Valvulotome|valvulotome]] that could be used by a surgeon to cut valves in peripheral veins without the requirement of direct vision.<ref>https://patents.google.com/patent/US5658301A/en</ref> As a result, the surgeon could prepare veins for arterial bypass with smaller incisions and less tissue trauma.<ref>https://jamanetwork.com/journals/jamasurgery/article-abstract/592908</ref> Dr. LeMaitre was so pleased with the success of his new device that he started a company to introduce the LeMaitre Valvulotome to his colleagues. In the ensuing years, Dr. LeMaitre’s son, George W. LeMaitre, joined the company and helped grow it from a family-owned company to a publicly held global corporation.


Today, in addition to the most recent generation of Dr. LeMaitre’s original valvulotome, LeMaitre Vascular develops, manufactures and markets disposable and implantable vascular devices for use in both open vascular surgeries and minimally invasive procedures. As a result of the company’s research and subsequent development of new vascular devices, as well as various acquisitions,<ref>{{Cite web|url=https://seekingalpha.com/article/4394401-lemaitre-widened-capital-structure-acquisitions-drive-top-line-growth|title=LeMaitre: Widened Capital Structure, Acquisitions Drive Top-Line Growth (NASDAQ:LMAT)|first=Zach|last=Bristow|date=December 12, 2020|website=Seeking Alpha}}</ref><ref>{{Cite web|url=https://vascularnews.com/lemaitre-vascular-acquires-artegraft/|title=LeMaitre Vascular acquires Artegraft|first=Jocelyn|last=Hudson|date=July 2, 2020}}</ref><ref>{{Cite web|url=https://www.massdevice.com/admedus-deals-biologic-patch-business-to-lemaitre-vascular-for-24m/|title=Admedus deals biologic patch business to LeMaitre Vascular for $24m|date=October 15, 2019|website=MassDevice}}</ref><ref>{{Cite web|url=https://finance.yahoo.com/news/lemaitre-vascular-acquires-cardial-business-205053866.html|title=LeMaitre Vascular Acquires Cardial Business of BD|website=finance.yahoo.com}}</ref><ref>{{Cite web|url=https://www.spglobal.com/marketintelligence/en/news-insights/trending/q2FN8qnYeIJ-Avc2GxY_nQ2|title=LeMaitre buys Applied Medical's clot management business for $14.2M|website=www.spglobal.com}}</ref><ref>{{Cite web|url=https://evtoday.com/news/lemaitre-vascular-acquires-assets-of-restore-flow-allografts|title=LeMaitre Vascular Acquires Assets of Restore Flow Allografts|website=Endovascular Today}}</ref> LeMaitre Vascular’s product portfolio includes brand name products used by surgeons in arteries and veins outside the heart.
Today, in addition to the most recent generation of Dr. LeMaitre’s original valvulotome, LeMaitre Vascular develops, manufactures and markets disposable and implantable vascular devices for use in both open vascular surgeries and minimally invasive procedures. As a result of the company’s research and subsequent development of new vascular devices,<ref> https://healthizmo.com/news/64128/key-players-in-the-clot-management-devices-market-teleflex-edwards-lifesciences-medtronic-boston-scientific-lemaitre-vascular-straub-medical-cook-medical-johnson-johnson-and-others</ref> as well as various acquisitions, LeMaitre Vascular’s product portfolio continues to grow.


== References ==
== References ==

Revision as of 22:57, 27 December 2020

  • Comment: Slightly adverty - "LeMaitre Vascular’s product portfolio includes brand name products used by surgeons in arteries and veins outside the heart." but mainly does not demonstrate notabily WP:N - see especially WP:CORPDEPTH which mitigates against financial announcement stories being markers of notability. Tagishsimon (talk) 02:36, 14 December 2020 (UTC)

LeMaitre Vascular is a provider of devices, implants and human tissue cryopreservation services used by surgeons in the treatment of vascular conditions, particularly peripheral vascular disease.[1] Headquartered in Burlington, Massachusetts, LeMaitre Vascular sells directly to hospitals in 22 countries and through distributors in more than 60 countries throughout North America, Europe and Asia/Pacific Rim.[2]

The company was founded in 1983 by George D. LeMaitre, M.D., a practicing vascular surgeon who wasn’t satisfied with the in situ devices that were available to him. He worked with an engineer to design a new device himself. His first patented creation was a type of valvulotome that could be used by a surgeon to cut valves in peripheral veins without the requirement of direct vision.[3] As a result, the surgeon could prepare veins for arterial bypass with smaller incisions and less tissue trauma.[4] Dr. LeMaitre was so pleased with the success of his new device that he started a company to introduce the LeMaitre Valvulotome to his colleagues. In the ensuing years, Dr. LeMaitre’s son, George W. LeMaitre, joined the company and helped grow it from a family-owned company to a publicly held global corporation.

Today, in addition to the most recent generation of Dr. LeMaitre’s original valvulotome, LeMaitre Vascular develops, manufactures and markets disposable and implantable vascular devices for use in both open vascular surgeries and minimally invasive procedures. As a result of the company’s research and subsequent development of new vascular devices,[5] as well as various acquisitions, LeMaitre Vascular’s product portfolio continues to grow.

References